Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Operating Cash Flow per Share : ¥0.04 (TTM As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co Operating Cash Flow per Share?

Henan Taloph Pharmaceutical Stock Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥-0.21. Henan Taloph Pharmaceutical Stock Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Henan Taloph Pharmaceutical Stock Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:600222' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -58.5 Med: 5.05 Max: 253
Current: -16.5

During the past 13 years, Henan Taloph Pharmaceutical Stock Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 253.00% per year. The lowest was -58.50% per year. And the median was 5.05% per year.

SHSE:600222's 3-Year OCF Growth Rate is ranked worse than
78.44% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs SHSE:600222: -16.50

Henan Taloph Pharmaceutical Stock Co Operating Cash Flow per Share Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co Operating Cash Flow per Share Chart

Henan Taloph Pharmaceutical Stock Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.08

0.13

0.18

-0.22

0.08

Henan Taloph Pharmaceutical Stock Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.16	0.01	0.06	0.17	-0.21

Competitive Comparison of Henan Taloph Pharmaceutical Stock Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Henan Taloph Pharmaceutical Stock Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's Price-to-Operating-Cash-Flow falls into.

Henan Taloph Pharmaceutical Stock Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Henan Taloph Pharmaceutical Stock Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	43.738	/	562.748
	=	0.08

Henan Taloph Pharmaceutical Stock Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-115.824	/	557.970
	=	-0.21

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.04

Henan Taloph Pharmaceutical Stock Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001

Website

http://www.taloph.com

Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.

Executives

Zhao Qing Xin

Director

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Headlines

No Headlines